Overview
- U.S. Bankruptcy Judge Sean Lane announced his approval from the bench Friday, with a formal explanation scheduled for Tuesday.
- Sackler family members must contribute up to $7 billion and give up ownership of Purdue, which will be restructured as Knoa Pharma under public‑interest oversight.
- Approximately $850 million is set aside for individuals, including more than $100 million for infants with opioid withdrawal, with typical payouts estimated near $16,000 for long‑term prescriptions.
- The plan allows entities that do not opt in to pursue lawsuits against Sackler family members, reflecting the Supreme Court’s prior rejection of broad liability shields.
- Non‑financial terms include public release of internal documents, limits on Sackler philanthropic naming rights, and restrictions on certain family members’ roles in opioid businesses abroad.